Under normal circumstances, immune checkpoints (ICPs) maintain self-tolerance and immune homeostasis, but when malignant tumors occur, ICPs are occupied, such as PD-L1 on tumor cells binding to PD-1 on T cells and thus preventing effector T cells from functioning, allowing tumor cells to achieve immune escape and promoting tumor growth [47]. This evidence concerns the gene CD274 and neoplasm.